{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:01:45Z","timestamp":1789786905628,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005006","name":"Asan Medical Center Asan Institute for Life Sciences","doi-asserted-by":"publisher","award":["2024IL0022-1"],"award-info":[{"award-number":["2024IL0022-1"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005006","name":"Asan Medical Center Asan Institute for Life Sciences","doi-asserted-by":"publisher","award":["2024IP0093\\u20131"],"award-info":[{"award-number":["2024IP0093\\u20131"]}],"id":[{"id":"10.13039\/501100005006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-RS-2023-00208928"],"award-info":[{"award-number":["NRF-RS-2023-00208928"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-RS-2023-00249112"],"award-info":[{"award-number":["NRF-RS-2023-00249112"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.neuint.2025.106087","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:42:54Z","timestamp":1763606574000},"page":"106087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Transcription factor EB inhibition in response to genotoxic stress promotes apoptosis of glioblastoma cells"],"prefix":"10.1016","volume":"191","author":[{"given":"Seung-Ho","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minseok","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jeong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-6163","authenticated-orcid":false,"given":"Kyung-Chul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2025.106087_bib1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106087_bib2","doi-asserted-by":"crossref","first-page":"7843","DOI":"10.1158\/0008-5472.CAN-06-1010","article-title":"Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor","volume":"66","author":"Bao","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuint.2025.106087_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127058","article-title":"The HDAC inhibitors scriptaid and LBH589 combined with the oncolytic virus Delta24-RGD exert enhanced anti-tumor efficacy in patient-derived glioblastoma cells","volume":"10","author":"Berghauser Pont","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2025.106087_bib4","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12032-014-0985-5","article-title":"Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience","volume":"31","author":"Bezecny","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.neuint.2025.106087_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.283","article-title":"Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide","volume":"4","author":"Biasoli","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuint.2025.106087_bib6","article-title":"The transcription factors TFE3 and TFEB amplify p53 dependent transcriptional programs in response to DNA damage","volume":"7","author":"Brady","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.neuint.2025.106087_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133161","article-title":"Survival outcomes and prognostic factors in glioblastoma","volume":"14","author":"Brown","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.neuint.2025.106087_bib8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nature11287","article-title":"A restricted cell population propagates glioblastoma growth after chemotherapy","volume":"488","author":"Chen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106087_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4161\/epi.25440","article-title":"Epigenetic pathways and glioblastoma treatment","volume":"8","author":"Clarke","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuint.2025.106087_bib10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0960327119892041","article-title":"Molecular mechanisms of cell death induced in glioblastoma by experimental and antineoplastic drugs: new and old drugs induce apoptosis in glioblastoma","volume":"39","author":"Contreras-Ochoa","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.neuint.2025.106087_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphar.2013.00089","article-title":"Mechanisms regulating resistance to inhibitors of topoisomerase II","volume":"4","author":"Ganapathi","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106087_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2015.07.008","article-title":"Increased expression of transcription factor EB (TFEB) is associated with autophagy, migratory phenotype and poor prognosis in non-small cell lung cancer","volume":"90","author":"Giatromanolaki","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.neuint.2025.106087_bib13","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.4161\/15384047.2014.955719","article-title":"Autophagy and lysosomal related protein expression patterns in human glioblastoma","volume":"15","author":"Giatromanolaki","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.neuint.2025.106087_bib14","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","article-title":"Etoposide: four decades of development of a topoisomerase II inhibitor","volume":"34","author":"Hande","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neuint.2025.106087_bib15","doi-asserted-by":"crossref","first-page":"15178","DOI":"10.1073\/pnas.2036535100","article-title":"Cancerous stem cells can arise from pediatric brain tumors","volume":"100","author":"Hemmati","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2025.106087_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrc2818","article-title":"Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma","volume":"10","author":"Huse","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuint.2025.106087_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/732413","article-title":"Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment","volume":"2011","author":"Jackson","year":"2011","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.neuint.2025.106087_bib18","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/s41467-025-56946-z","article-title":"Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastoma","volume":"16","author":"Jing","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106087_bib19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.cdd.4401359","article-title":"Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells","volume":"11","author":"Kanzawa","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuint.2025.106087_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrurol.2014.162","article-title":"Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers","volume":"11","author":"Kauffman","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.neuint.2025.106087_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3892\/ijo.2016.3505","article-title":"Role of TFEB-Driven autophagy regulation in pancreatic cancer treatment","volume":"49","author":"Klein","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.neuint.2025.106087_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/OP.22.00476","article-title":"Key clinical principles in the management of glioblastoma","volume":"19","author":"Kotecha","year":"2023","journal-title":"JCO Oncol. Pract."},{"key":"10.1016\/j.neuint.2025.106087_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12951-015-0122-4","article-title":"Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells","volume":"13","author":"Kwak","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.neuint.2025.106087_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41589-022-01235-9","article-title":"Etoposide promotes DNA loop trapping and barrier formation by topoisomerase II","volume":"19","author":"Le","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuint.2025.106087_bib25","doi-asserted-by":"crossref","first-page":"18577","DOI":"10.18632\/oncotarget.14612","article-title":"Advances in epigenetic glioblastoma therapy","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuint.2025.106087_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bcp.2018.02.026","article-title":"STAT3 contributes to lysosomal-mediated cell death in a novel derivative of riccardin D-treated breast cancer cells in association with TFEB","volume":"150","author":"Li","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106087_bib27","article-title":"Lysosomal dysfunction and autophagy blockade contribute to IMB-6G-induced apoptosis in pancreatic cancer cells","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106087_bib28","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1093\/hmg\/ddx214","article-title":"TFEB activation restores migration ability to Tsc1-deficient adult neural stem\/progenitor cells","volume":"26","author":"Magini","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2025.106087_bib29","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/ncomms3130","article-title":"ATG5 is induced by DNA-damaging agents and promotes mitotic catastrophe independent of autophagy","volume":"4","author":"Maskey","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2025.106087_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1144184","article-title":"The function of histone methylation and acetylation regulators in GBM pathophysiology","volume":"13","author":"McCornack","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuint.2025.106087_bib31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.semcancer.2009.02.005","article-title":"Epigenetic mechanisms in glioblastoma multiforme","volume":"19","author":"Nagarajan","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.neuint.2025.106087_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0005-2728(93)90079-U","article-title":"The mechanisms by which mild respiratory chain inhibitors inhibit hepatic gluconeogenesis","volume":"1142","author":"Owen","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2025.106087_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.drudis.2021.08.004","article-title":"Vorinostat in autophagic cell death: a critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention","volume":"27","author":"Patra","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.neuint.2025.106087_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140131","article-title":"Temozolomide resistance in glioblastoma cell lines: implication of MGMT, MMR, P-Glycoprotein and CD133 expression","volume":"10","author":"Perazzoli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2025.106087_bib35","first-page":"860","article-title":"Oral etoposide","volume":"22","author":"Phillips","year":"1988","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.neuint.2025.106087_bib36","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","article-title":"Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma","volume":"28","author":"Qazi","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neuint.2025.106087_bib37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.molonc.2015.12.014","article-title":"Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma","volume":"10","author":"Rasmussen","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.neuint.2025.106087_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cncr.22741","article-title":"Molecularly targeted therapy for malignant glioma","volume":"110","author":"Sathornsumetee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.neuint.2025.106087_bib39","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuint.2025.106087_bib40","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00432-011-1046-5","article-title":"Etoposide-mediated glioblastoma cell death: dependent or independent on the expression of its target, topoisomerase II alpha?","volume":"137","author":"Sevim","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.neuint.2025.106087_bib41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106087_bib42","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302259","article-title":"Transcription factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress","volume":"8","author":"Soleimani","year":"2025","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.neuint.2025.106087_bib43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2025.106087_bib44","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2014.9.FOCUS14494","article-title":"The role of cancer stem cells in glioblastoma","volume":"37","author":"Sundar","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.neuint.2025.106087_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12556","article-title":"Inhibition of TFEB oligomerization by co-treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells","volume":"66","author":"Sung","year":"2019","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neuint.2025.106087_bib46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bjc.6600673","article-title":"Chemotherapy for malignant pleural mesothelioma: past results and recent developments","volume":"88","author":"Tomek","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neuint.2025.106087_bib47","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1158\/0008-5472.CAN-08-3886","article-title":"Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors","volume":"69","author":"Wakimoto","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuint.2025.106087_bib48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuint.2025.106087_bib49","first-page":"599","article-title":"Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells","volume":"27","author":"Xie","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuint.2025.106087_bib50","first-page":"1043","article-title":"Importance of TFEB acetylation in control of its transcriptional activity and lysosomal function in response to histone deacetylase inhibitors","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.neuint.2025.106087_bib51","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1158\/0008-5472.CAN-05-0453","article-title":"2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro","volume":"65","author":"Zhu","year":"2005","journal-title":"Cancer Res."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:36:52Z","timestamp":1773833812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018625001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":51,"alternative-id":["S0197018625001603"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106087","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcription factor EB inhibition in response to genotoxic stress promotes apoptosis of glioblastoma cells","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106087"}}